Ovid Therapeutics Inc. Debt Securities, Available-for-sale
Ovid Therapeutics Inc. (OVID) had Debt Securities, Available-for-sale of $158.44 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2026-08-13
- 2026-06-30: Debt Securities, Available-for-sale $158.44M.
- 2026-03-31: Debt Securities, Available-for-sale $71.53M.
- 2025-12-31: Debt Securities, Available-for-sale $77.29M.
- 2025-09-30: Debt Securities, Available-for-sale $4.99M.
| Period end | Debt Securities, Available-for-sale | Debt Securities, Available-for-sale as first filed |
|---|---|---|
| 2026-06-30 | $158.44M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $71.53M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $77.29M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $4.99M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $9.93M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $21.86M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $26.77M 10-K · filed 2026-03-18 | |
| 2024-09-30 | $47.70M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $47.28M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $59.49M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $78.79M 10-K · filed 2025-03-11 | $78.79M 10-K · filed 2024-03-08 |
| 2023-09-30 | $29.64M 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $24.89M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $54.67M 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $84.13M 10-K · filed 2024-03-08 | |
| 2022-09-30 | $79.60M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $79.55M 10-Q · filed 2022-08-09 | |
| 2021-12-31 | $0.00 10-K · filed 2023-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |